×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CNTX – context therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CNTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/24
03:02 pm
cntx
Context Therapeutics (CNTX) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $9.00 price target on the stock.
Low
Report
Context Therapeutics (CNTX) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $9.00 price target on the stock.
3/24
09:50 am
cntx
Context Therapeutics (CNTX) had its "buy" rating reaffirmed by Guggenheim. They now have a $5.00 price target on the stock.
Low
Report
Context Therapeutics (CNTX) had its "buy" rating reaffirmed by Guggenheim. They now have a $5.00 price target on the stock.
3/24
09:17 am
cntx
Context Therapeutics (CNTX) had its price target raised by Piper Sandler from $4.00 to $7.00. They now have an "overweight" rating on the stock.
Medium
Report
Context Therapeutics (CNTX) had its price target raised by Piper Sandler from $4.00 to $7.00. They now have an "overweight" rating on the stock.
3/23
05:09 pm
cntx
Context Therapeutics Reports Full Year 2025 Operating and Financial Results [Yahoo! Finance]
Medium
Report
Context Therapeutics Reports Full Year 2025 Operating and Financial Results [Yahoo! Finance]
3/23
04:24 pm
cntx
Context Therapeutics GAAP EPS of -$0.38 [Seeking Alpha]
Medium
Report
Context Therapeutics GAAP EPS of -$0.38 [Seeking Alpha]
3/23
04:16 pm
cntx
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Medium
Report
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
3/21
01:31 am
cntx
Context Therapeutics (CNTX) was upgraded by Wall Street Zen from "sel
Low
Report
Context Therapeutics (CNTX) was upgraded by Wall Street Zen from "sel
3/19
07:30 am
cntx
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
Low
Report
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/23
04:22 pm
cntx
Form 8-K Context Therapeutics For: Mar 23
Medium
Report
Form 8-K Context Therapeutics For: Mar 23
3/23
04:10 pm
cntx
Form 10-K Context Therapeutics For: Dec 31
Medium
Report
Form 10-K Context Therapeutics For: Dec 31
3/13
04:09 pm
cntx
Form 8-K Context Therapeutics For: Mar 11
Medium
Report
Form 8-K Context Therapeutics For: Mar 11
2/27
04:14 pm
cntx
Form 8-K Context Therapeutics For: Feb 24
Low
Report
Form 8-K Context Therapeutics For: Feb 24
2/23
04:25 pm
cntx
Form 4 Context Therapeutics For: Feb 19 Filed by: Levit Alex C.
Medium
Report
Form 4 Context Therapeutics For: Feb 19 Filed by: Levit Alex C.
2/23
04:22 pm
cntx
Form 4 Context Therapeutics For: Feb 19 Filed by: Minai-Azary Jennifer Lynn
Medium
Report
Form 4 Context Therapeutics For: Feb 19 Filed by: Minai-Azary Jennifer Lynn
2/23
04:19 pm
cntx
Form 4 Context Therapeutics For: Feb 19 Filed by: Chagin Karen Deborah
Medium
Report
Form 4 Context Therapeutics For: Feb 19 Filed by: Chagin Karen Deborah
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: